News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>Citi: Keeta Delays Expansion Plan into Rio de Janeiro; MEITUAN-W Still Faces Intense Competition in CN Biz
Keeta's delay in entering the Rio de Janeiro market is not surprising, which Keeta attributed to numerous exclusive agreements by competitors, Citi Research published a researc...
Reset
Send
The window will close in 5 seconds
<Research>Citi: Keeta Delays Expansion Plan into Rio de Janeiro; MEITUAN-W Still Faces Intense Competition in CN Biz
Close
Recommend
34
Positive
41
Negative
30
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

Keeta's delay in entering the Rio de Janeiro market is not surprising, which Keeta attributed to numerous exclusive agreements by competitors, Citi Research published a research report saying.

The broker believed that this setback, along with the layoff of 200 local employees, may provide positive insights for competitors like Didi and iFood, potentially alleviating pressure on Didi's assumption of international business EBITDA loss in 2026.

Related News Haitong International Raises Meituan (03690.HK) TP to HKD115, Upgrades Rating to 'Outperform'
Nevertheless, MEITUAN-W (03690.HK)  -1.700 (-2.074%)    Short selling $939.39M; Ratio 62.972%   continued to face intense competition in its China business. Therefore, Citi Research kept rating at Neutral/ High Risk, with a target price of $94.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.